Award Terms & Conditions, Federal Regulations and Policies
CDC grant and cooperative agreement recipients must comply with all applicable terms and conditions of their awards, federal laws, regulations, and policies.
Applicable grant terms and conditions, policies and regulations include:
- CDC General Terms and Conditions for Research Awardspdf icon
- CDC General Terms and Conditions for Non-research Awardspdf icon
- Code of Federal Regulations (CFRs)
- HHS Grants Policy Statementpdf iconexternal icon
- Federal Funding Accountability and Transparency Act (FFATA)external icon
- Anti-Lobby Restrictions for CDC Grant Recipientspdf icon
- Grantee Notification Guidance on the Establishment of Subaccountspdf icon
- Notice of Funding Opportunity Additional Requirements
Recipients must comply with all general terms and conditions above and specific terms and conditions detailed in the Notice of Award (NoA). The NoA includes additional program and recipient special conditions.
On June 4, 2020, HHS announcedexternal icon guidance on laboratory data reporting as required under section 18115 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136). The guidancepdf iconexternal icon specifies requirements for data submission from laboratories and from state and local public health departments using existing reporting channels. Consistent with the terms and conditions of grants and cooperative agreements awarding coronavirus supplemental funding, recipients must comply with this guidance, as applicable. For more information, see the HHS Frequently Asked Questionspdf iconexternal icon about laboratory data reporting.
Additionally, the directives below apply to all CDC COVID-19 Vaccination Program enrolled providers and all awardees and recipients of HHS (which includes CDC) grant and cooperative agreement funds, including grants to states and U.S. territories that have been awarded to support, implement, and expand COVID-19 vaccination programs nationwide.
- Secretarial Directive for Prioritization of COVID-19 Vaccines and Administration for Certain Educational and Child Care Workers (March 2, 2021)pdf iconexternal icon
- Secretarial Directive on Eligibility to Receive COVID-19 Vaccines (March 17, 2021)pdf iconexternal icon
- Secretarial Directive on Availability of Covid-19 Vaccines for Children Ages 5 through 11 (November 3, 2021)pdf iconexternal icon
- Secretarial Directive on Availability of Booster Doses of COVID-19 Vaccines (November 21, 2021)pdf iconexternal icon, replaced previous directives from September 25, 2021, and October 22, 2021
In 2019, CDC provided expanded authority for carryover to some awards, allowing recipients to spend unobligated funds in a following budget period for any approved cost that falls within the scope and objectives of a project. For more information about expanded authority, please refer to the Expanded Authority for Carryover Fact Sheetpdf icon. To determine if expanded authority for carryover has been granted for an award, refer to your NoA document for the special terms and conditions .